Clinical Trial Update: Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase I/II trial evaluating an immune therapy given after allogeneic transplantation in patients with myeloid hematologic diseases, including acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Acute Myeloid Leukemia, Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED